Enhanced benefits and award-winning patient engagement solutions for pediatric practices.
CHARLOTTE, N.C., Sept. 24, 2024 /PRNewswire/ — InteliChart, an award-winning provider of patient engagement technology, is excited to announce the extension of our partnership with Office Practicum (OP). Under this new multi-year agreement, OP customers will be able to work directly with InteliChart for all their patient engagement needs.
For years, OP customers have trusted InteliChart to power their Patient Portal. Now, by transitioning to a direct partnership, these practices will gain additional support, personalized training, and the full range of InteliChart’s patient engagement tools, all designed to help pediatric practices thrive.
Leading the Industry in Patient Engagement
InteliChart has long been recognized as a leader in the patient engagement space. The platform has been ranked the #1 patient engagement solution by Black Book Research for two consecutive years (2023 and 2024), earning top ratings in key areas such as Training, Support, and Customer Care. Additionally, InteliChart’s Patient Portal is a top performer in its KLAS rating, receiving impressive customer satisfaction scores substantially above the KLAS average scores.
“Providing a superior patient engagement experience has always been our top priority,” said Gary Hamilton, CEO of InteliChart. “Through our extended agreement with Office Practicum, we’re excited to offer pediatric practices even greater value with award-winning support, personalized training, and solutions designed to streamline operations and enhance patient care.”
Exclusive Benefits for Office Practicum Practices
Office Practicum customers who choose to work with InteliChart directly will receive:
“Although Office Practicum customers have been using the InteliChart Patient Portal for years, we recognize that their success depends on how effectively they can leverage its capabilities,” said Hamilton. “That’s why the training and support provided to Office Practicum customers are critical for unlocking the portal’s full potential, enhancing both patient engagement and operational efficiency.”
Partnering directly with InteliChart is designed to be a smooth and efficient process, with zero disruption to practice operations or existing workflows. Office Practicum customers that are interested in transitioning to a direct partnership with InteliChart can learn more here: https://www.intelichart.com/intelichart-office-practicum-transition
About InteliChart
InteliChart delivers the award-winning Healthy Outcomes patient-engagement platform. This platform is tailored to help healthcare providers meet the digital health expectations of patients and achieve optimal health outcomes. Their comprehensive suite of patient engagement solutions includes the Patient Portal, Family Portal, Patient Intake, Patient Notify, Patient Survey, Patient Schedule, Patient Activate, and Patient eHealth.
Renowned EHR vendors, hospitals, health systems, and medical practices have chosen InteliChart as their preferred patient engagement platform. These collective endorsements represent over 80 million patient records. InteliChart maintains API integration with more than 40 EHR systems, enabling seamless access to the entire suite of Healthy Outcomes solutions. For more detailed information about InteliChart and the Healthy Outcomes platform, visit www.intelichart.com.
Media Contact:
Yancey Casey
Amendola Communications on behalf of InteliChart
(678) 895-9401
ycasey@acmarketingpr.com
SOURCE InteliChart, LLC
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients…
TAMPA, Fla.--(BUSINESS WIRE)--#cryotherapy--Next Health, the world's most advanced brand of proactive healthcare centers, is bringing…
TORONTO, ON / ACCESSWIRE / September 27, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma…
Visit Covalon at booth 523 to discover the latest in compassionate vascular access solutions MISSISSAUGA,…
WASHINGTON & OXFORD, England--(BUSINESS WIRE)--#Healthcare--Perspectum announced two research studies that were recently published, bringing hope…
SHANGHAI, Sept. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading…